These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7946958)

  • 1. Genetic analysis of breast and ovarian cancer in families.
    King MC; Rowell S
    Cancer Treat Res; 1994; 71():51-62. PubMed ID: 7946958
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited breast and ovarian cancer. What are the risks? What are the choices?
    King MC; Rowell S; Love SM
    JAMA; 1993 Apr; 269(15):1975-80. PubMed ID: 8464130
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.
    Go RC; King MC; Bailey-Wilson J; Elston RC; Lynch HT
    J Natl Cancer Inst; 1983 Sep; 71(3):455-61. PubMed ID: 6577220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic linkage study of familial breast-ovarian cancer.
    Ferrell RE; Anderson DE; Chidambaram A; Marino TR; Badzioch M
    Cancer Genet Cytogenet; 1989 Apr; 38(2):241-8. PubMed ID: 2720637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of familial breast-ovarian cancer.
    van Rensburg EJ; Ponder BA
    J Clin Pathol; 1995 Sep; 48(9):789-95. PubMed ID: 7490308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hereditary predisposition for cancer of the breast and the ovary].
    Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
    Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation to determine whether clusters of cancer types exist in nine breast-ovary families.
    Bansal A; Bishop DT; Cannings C
    Genet Epidemiol; 1995; 12(6):841-6. PubMed ID: 8788019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
    Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
    J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.
    Sinilnikova OM; Mazoyer S; Bonnardel C; Lynch HT; Narod SA; Lenoir GM
    Fam Cancer; 2006; 5(1):15-20. PubMed ID: 16528604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary and familial ovarian cancer in southern Ontario.
    Narod SA; Madlensky L; Bradley L; Cole D; Tonin P; Rosen B; Risch HA
    Cancer; 1994 Oct; 74(8):2341-6. PubMed ID: 7922985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW
    Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 mutations in German breast-cancer families.
    Jandrig B; Grade K; Seitz S; Waindzoch B; Müller M; Bender E; Nothnagel A; Rohde K; Schlag PM; Kath R; Höffken K; Scherneck S
    Int J Cancer; 1996 Oct; 68(2):188-92. PubMed ID: 8900426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
    Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
    J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.
    Thompson ER; Boyle SE; Johnson J; Ryland GL; Sawyer S; Choong DY; kConFab ; Chenevix-Trench G; Trainer AH; Lindeman GJ; Mitchell G; James PA; Campbell IG
    Hum Mutat; 2012 Jan; 33(1):95-9. PubMed ID: 21990120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial ovarian cancer].
    Ben David Y; Shalev E
    Harefuah; 1997 Jun; 132(12):858-61. PubMed ID: 9264194
    [No Abstract]   [Full Text] [Related]  

  • 18. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for the familial breast/ovarian cancer gene.
    Black DM; Solomon E
    Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial association of carcinoma of the breast and ovary.
    Lynch HT; Guirgis HA; Albert S; Brennan M; Lynch J; Kraft C; Pocekay D; Vaughns C; Kaplan A
    Surg Gynecol Obstet; 1974 May; 138(5):717-24. PubMed ID: 4823374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.